Neoimmunetech

This study tested a combination of two drugs (NT-I7 and pembrolizumab) in 215 adults with advanced solid tumors that had come back or stopped responding to standard treatments. The goal was to find a safe dose and see if the combo could shrink tumors. The study also looked at imm…

This early-phase study tested a drug called NT-I7 (a long-acting immune booster) given after standard CAR-T cell therapy in 17 adults with large B-cell lymphoma that had come back or not responded to prior treatments. The main goal was to check safety and find the best dose. Rese…